Interferon-γ and Management of Infectious Diseases

  1. Steven M. Holland, MD;
  2. Joshua M. Farber, MD; and
  3. John I. Gallin, MD
  1. National Institute of Allergy and Infectious Diseases; National Institutes of Health; Bethesda, MD 20189

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, …

    « Previous | Next Article »Table of Contents